BUZZ-U.S. STOCKS ON THE MOVE-Brainstorm, MiMedx, Perfect World
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes edged lower on Friday, erasing earlier gains as investors found few reasons to buy in the new year as crude oil prices continued to weaken and data came in below forecasts. The Dow Jones industrial average was down 0.22 percent at 17,783.93, the S&P 500 was down 0.33 percent at 2,052.11 and the Nasdaq Composite was down 0.59 percent at 4,708.334.
** MIMEDX GROUP INC, $9.27, -19.60 pct
The wound care product maker said late on Wednesday that it received a subpoena from the Office of Inspector General of the Department of Health and Human Service, related to a civil investigation into matters related to its sales and marketing activities. MiMedx also said it had filed a lawsuit against rival Organogenesis Inc for malicious actions.
"We believe the biggest risk is that the investigation could cause MDXG's growth to slow," Needham & Co LLC analysts wrote in a note.
** BRAINSTORM CELL THERAPEUTICS INC, $7.44, +56.30 pct
Data is expected on Monday on the mid-stage trial of the Israeli stem cell technology developer's stem cell therapy technology, NurOwn, in patients with amytrophic lateral sclerosis.